Thyrotropin-releasing hormone (TRH) is an important extracellular regulatory molecule that functions as a releasing factor in the anterior pituitary gland and as a neurotransmitter/neuromodulator in the central and peripheral nervous systems. Binding sites for TRH are present in these tissues, but the TRH receptor (TRH-R) has not been purified from any source. Using Xenopus laevis oocytes in an expression cloning strategy, we have isolated a cDNA clone that encodes the mouse pituitary TRH-R. This conclusion is based on the following evidence. Injection of sense RNA transcribed in vitro from this cDNA into Xenopus oocytes leads to expression of cell-surface receptors that bind TRH and the competitive antagonist chlordiazepoxide with appropriate affinities and that elicit electrophysiological responses to TRH with the appropriate concentration dependency. Antisense RNA inhibits the TRH response in Xenopus oocytes ijected with RNA isolated from normal rat anterior pituitary glands. Finally, transfection of COS-1 cells with this cDNA leads to expression of receptors that-bind TRH and chlordiazepoxide with appropriate affinities and that transduce TRH stimulation of inositol phosphate formation. The 3.8-kilobase mouse TRH-R cDNA encodes a protein of 393 amino acids that shows similarities to other guanine nucleotide-binding regulatory protein-coupled receptors.
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Thyrotropin-releasing hormone (TRH), which was initially isolated from the hypothalamus and thought to function solely as a releasing factor for the anterior pituitary gland, has been shown to be distributed widely throughout the central and peripheral nervous systems as well as in extraneural tissues (1, 2) . TRH receptors (TRH-R) are present in the pituitary (3) and brain (4) . Binding sites for TRH, which probably represent receptors that serve as transmembrane signaling proteins, have also been found in other tissues. Pharmacological evidence suggests that the pituitary and brain receptors are similar but that they exhibit different isoelectric points (5) . The question of whether there are TRH-R subtypes, as is the case for other guanine nucleotidebinding regulatory protein (G protein)-coupled receptors (6) , remains open.
Transmembrane signaling by the pituitary TRH-R has been studied intensively, and it has been shown that TRH acts via the inositol phospholipid-calcium-protein kinase C transduction pathway (7) . Indirect evidence (8, 9) is consistent with the hypothesis that a G protein couples the TRH-R to a phospholipase C that hydrolyzes phosphatidylinositol 4,5- bisphosphate. Therefore , it has been assumed that the TRH-R is a member of the large family of G protein-coupled receptors. However, attempts to purify the TRH-R protein by conventional biochemical techniques have not been successful (10, 11) . To study in detail the molecular mechanisms of TRH-R signaling, the regulation of TRH-R number and mRNA levels under different physiological conditions, and whether different subtypes exist for the TRH-R, we isolated a cDNA encoding the mouse pituitary TRH-R. In this report we describe the isolation and sequence$ of this cDNA and present ligand binding and response characteristics of the receptor expressed in Xenopus oocytes and in transfected mammalian cells that show that it encodes the pituitary TRH-R.
MATERIALS AND METHODS
Expression Cloning of the Mouse TRH-R cDNA. A directional, size-selected cDNA library was constructed by using our previously reported method (12) . Poly(A)+ RNA was isolated from a mouse pituitary thyrotropic TtT tumor (13) and fractionated on a sucrose gradient. The fraction that gave the highest specific TRH-R mRNA activity when injected into stage 5 or 6 Xenopus laevis oocytes (14, 15) was used for preparative cDNA synthesis. To find an enzyme that would generate the highest yield of long cDNAs, we compared seven lots of murine leukemia virus reverse transcriptase from four manufacturers using as test templates RNA fractions from the sucrose gradient adjacent to the one with the highest specific TRH-R mRNA activity. cDNAs of between 3 and 5 kilobases (kb) were purified by agarose gel electrophoresis and electroelution. The size-selected cDNAs were ligated directionally into AZAP (Stratagene) such that transcription using T7 RNA polymerase would yield sense RNA. A library of 1.2 x 106 clones was constructed that was >95% recombinant. The primary library was immediately divided and amplified individually in 60 sublibraries of approximately 20,000 clones each. Phage A DNA was prepared by the cetylmethylammonium bromide DNA precipitation method (16) . The 9The sequence reported in this paper has been deposited in the GenBank data base (accession no. M37490).
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DNA Sequencing. The plasmid Bluescript (pBSmTRHR) was excision-rescued from the TRH-R AZAP clone by coinfection with helper phage R408. Restriction fragments of the cDNA were subcloned into M13mpl9 and sequenced by the dideoxy chain-termination method of Sanger et al. (19) .
Expression and Phanmacological Characterization in Oocytes.
Xenopus oocytes were injected with 5 ng of sense RNA transcripts and were assayed for specific binding of TRH and electrophysiological responses to TRH. Binding to intact oocytes was performed as described (20) Proc. Natl. Acad. Sci. USA 87 (1990) observed in GH3 cells when rapid effects of TRH, such as generation of inositol 1,4,5-trisphosphate or elevation of cytoplasmic calcium, were measured (9, 27) .
Antisense RNA Inhibition of the Oocyte TRH Response. To ascertain if the cloned mouse TRH-R sequence is similar to endogenous rat pituitary TRH-R mRNA, we determined whether antisense RNA transcribed in vitro from a portion of the TRH-R cDNA in pBluescript (pBSmTRHR1.8) would inhibit TRH-R expression in oocytes injected with RNA isolated from normal rat anterior pituitary glands. Injection of RNA isolated from normal rat pituitaries led to acquisition of responses to TRH and carbachol, a muscarinic agonist (Fig.  3 Upper, left trace); there were no intrinsic responses to TRH or carbachol in uninjected collagenase-treated oocytes. In Fig. 3 Upper, right trace, are responses from an oocyte injected with RNA from normal rat pituitaries that had been incubated with antisense TRH-R RNA. The TRH response in the oocyte was abolished, but the carbachol response was unaffected. As shown in the compilation of data in Fig. 3 Lower, when antisense RNA was allowed to hybridize to rat pituitary RNA prior to injection, the response to TRH was inhibited by 87%, whereas the response to carbachol was not significantly inhibited.
Expression in COS-1 Cells. To examine both ligand binding and response characteristics of the cloned receptor in a mammalian system, we transfected COS-1 cells transiently with the TRH-R cDNA subcloned into the eukaryotic expression vector pCDM8 that contains the cytomegalovirus promoter (22) (Fig. 4 Upper). The Ki values for TRH (10 nM) and for chlordiazepoxide (20 ,uM) agree with those found in both oocytes injected with RNA transcribed in vitro from pBSmTRHR (Fig. 2 Upper) and in GH3 cells (26) . TRHstimulated inositol phosphate formation is shown in Fig. 4 Lower. TRH exhibited an EC50 of approximately 10 nM, which is similar to the EC50 found in oocytes injected with RNA transcribed in vitro from pBSmTRHR (Fig. 2 Lower) and in GH3 cells (9, 27) .
Primary Structure of the TRH-R. The nucleotide sequence and complete deduced amino acid sequence of the mouse TRH-R are shown in Fig. 5 . have been proposed to engage in a disulfide bond (30) are acylated by palmitic acid in the P2 receptor (32) . Fifteen of the present in extracellular loops 1 (Cys-98) and 2 (Cys-179).
last 52 amino acids are either serine or threonine, potential
These residues also may form a disulfide bond in the TRH-R sites for regulatory phosphorylation (6) . Candidates for phosbecause it has been shown that TRH binding is markedly phorylation by protein kinase C (33) include three residues in reduced when disulfide bonds are disrupted (31) . A cysteine intracellular loop 3 (Thr-250, Ser-259, and Ser-260) and four in present in the C terminus close to transmembrane domain the C terminus (Ser-324, Thr-342, Ser-360, and Thr-379). The M-VII (Cys-335) is homologous to the cysteine that may be third intracellular loop has been shown to be important in (45) , turkey ,1 receptor (T BAR) (46) , putative dog thyroid receptor RDC8 (D RDC8) (47) , rat dopamine D2 receptor (R D2) (48) , and rat muscarinic M5 receptor (R M5) (49) . Sequences were chosen for alignment based on searches of the Genpept (GenBank) and Swiss-Prot (EMBL) data bases using the program FASTA (42) . An initial alignment was produced by using the program GENALIGN (50) and adjusted manually to align the conserved residues indicated by asterisks. Putative membrane spanning domains for the TRH-R were assigned based on hydrophobicity analysis (28, 29) . Numbers present in the sequences indicate the number of residues not shown within each gap.
coupling to G proteins (6) . In the TRH-R, amino acids 227-235 of this region can be predicted (34) to form an amphipathic helix, a secondary structure that may be necessary for G-protein activation (35) .
Prolines, which in bacteriorhodopsin impart bends to the transmembrane helices (36) , are present in transmembrane domains M-V, M-VI, and M-VII, but there is no proline in M-IV. While most receptors in this family have prolines in all four final transmembrane domains, some receptors, including the thyrotropin receptor (37), luteinizing hormonechorionic gonadotropin (LH-CG) receptor (38) , and masencoded protein (39) do not. M-III does not contain aspartic acid which has been shown to be necessary for agonist binding to the p receptor (40) and is present in all adrenergic, muscarinic, serotonin, and dopamine receptors but is absent in the visual opsins, mas-encoded proteins, and receptors for thyrotropin, LH-CG, substance K, and substance P. Likewise, the TRH-R does not contain the serines in M-V that have been proposed to interact with the hydroxyl groups of ligands that contain a catechol moiety (41) .
Sequence Identity with Other Receptors. When the mouse TRH-R amino acid sequence was used to search (42) the Genpept (GenBank) and Swiss-Prot (EMBL) data bases, the results indicated significant sequence identity with only some of those receptors proposed to couple to G proteins. The alignment of the TRH-R with these members of the family of G protein-coupled receptors is shown in Fig. 6 . When the transmembrane domains only are compared, the percent identity is as follows: rat substance P receptor (43) (42) confirmed that these receptors share common ancestry and also that the mouse TRH-R is much less related to other receptors such as the dog thyrotropin receptor (37) , pig LH-CG receptor (38) , rat masencoded protein (39) , yeast A factor (52) , Dictyostelium cAMP receptor (53) , and pHS1-2 (54).
In conclusion, we have cloned the mouse pituitary TRH-R.
This isolation of a cDNA encoding the TRH-R, which may be the initial cloning of a cDNA for any hypothalamic releasing factor receptor, will permit analysis of the structure, function, and regulation of the receptor to proceed at the molecular level.
